Tufts Center for the Study of Drug Development's "Outlook 2005"

Overview:

This 12-page report from Tufts University's Center for the Study of Drug Development (CSDD) provides an overview of current pharmaceutical R&D trends. Among their conclusions, the report's authors said advances in biotechnology R&D, which are driving new product development and improving success rates, will result in nearly 50 new biotech medicines receiving FDA approval.